VARIZIG
VARIZIG
Discontinued
DIN Number
02243342
Drug Class
Human
Market Date
Feb 13, 2006
Company
HC
cangene corporation a subsidiary of emergent biosolutions inc.
Product Information
Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.
Product Details
Health Canada regulatory and product classification information
Regulatory Identifiers
DIN Number02243342
AIG Number0115174003
Classification & Schedule
C
Drug Class
Human
S
Schedule
Schedule D
A
ATC Code
J06BB03 VARICELLA/ZOSTER IMMUNOGLOBULIN
Product Specifications
Dosage FormKit
Route of AdministrationIntravenous
,
Intramuscular
AHFS Classification80:04.00
Health Canada Classification
ACTIVE INGREDIENTS (1)
VARICELLA ZOSTER IMMUNOGLOBULIN (HUMAN)Active
Strength: 125 UNIT / VIAL
Monograph: VARICELLA ZOSTER IMMUNOGLOBULIN (HUMAN)